In HFpEF, the systemic and cardiac inflammation results from metabolic risk factors (type 2 diabetes, obesity, and hypertension) and causes the activation of the endothelium in myocardial microcirculation, leading to the upregulation of NADPH oxidase 2 (NOX2) [5]. The gene discussed is CYBB; the disease is obesity disorder.